News

Home / News

To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2025/08/04 for the second quarter of 2025

To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2025/08/04 for the second quarter of 2025

2025.7.25

...

More

TSH Biopharm Wins Dual Honors at the 2025 AREA Asia Responsible Enterprise Awards

TSH Biopharm Wins Dual Honors at the 2025 AREA Asia Responsible Enterprise Awards

2025.6.27

...

More

TSH Biopharm was invited to attend the online institutional investor conference hosted by Concord Securities

TSH Biopharm was invited to attend the online institutional investor conference hosted by Concord Securities

2025.6.2

...

More

Important resolutions of the Company's 2025 General Shareholders' Meeting

Important resolutions of the Company's 2025 General Shareholders' Meeting

2025.5.28

...

More

Announcement of the Ex-dividend Record Date of Cash Dividends

Announcement of the Ex-dividend Record Date of Cash Dividends

2025.5.28

...

More

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD., regarding the release of non-competition restrictions for Directors

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD., regarding the release of non-competition restrictions for Directors

2025.5.20

...

More